Second, in order to bypass TCR/CAR suppression by the tumor microenvironment, induction of IL-2 production must be independent of the TCR activation pathway (e.g. NFAT promoter induced IL-2 still requires TCR/CAR activation to be triggered). Here, IL2 is linked to neoplasm.